Cantillon Capital Management Llc Decreased Agilent Technologies Inc (NYSE:A) Stake By $21.28 Million

February 14, 2018 - By Marguerite Chambers

Investors sentiment increased to 1.4 in 2017 Q3. Its up 0.18, from 1.22 in 2017Q2. It improved, as 26 investors sold A shares while 166 reduced holdings. 74 funds opened positions while 194 raised stakes. 267.56 million shares or 0.84% less from 269.83 million shares in 2017Q2 were reported. Moreover, Dekabank Deutsche Girozentrale has 0.03% invested in Agilent Technologies, Inc. (NYSE:A) for 58,315 shares. Regions Fincl Corporation holds 0.02% in Agilent Technologies, Inc. (NYSE:A) or 22,887 shares. 22,175 are owned by Nippon Life Ins. Cornerstone Cap Mgmt stated it has 0.03% of its portfolio in Agilent Technologies, Inc. (NYSE:A). Moreover, Gamco Incorporated Et Al has 0.05% invested in Agilent Technologies, Inc. (NYSE:A). Geode Capital Mgmt Ltd Liability Corp accumulated 3.48M shares. Ubs Asset Mgmt Americas Inc holds 982,962 shares or 0.06% of its portfolio. Moreover, Meag Munich Ergo Kapitalanlagegesellschaft Mbh has 0.12% invested in Agilent Technologies, Inc. (NYSE:A). Wells Fargo And Mn has 0.04% invested in Agilent Technologies, Inc. (NYSE:A) for 2.18 million shares. Nomura Asset Limited reported 43,166 shares. Nuveen Asset Mgmt holds 0.08% or 195,029 shares in its portfolio. Smithfield, Pennsylvania-based fund reported 525 shares. Tiemann Inv Advsr Ltd Liability Com holds 4,520 shares or 0.25% of its portfolio. Capital Finance Advisers Ltd Company has invested 0.02% in Agilent Technologies, Inc. (NYSE:A). Private Trust Na holds 8,495 shares or 0.12% of its portfolio.

Since August 16, 2017, it had 0 insider buys, and 10 selling transactions for $14.15 million activity. HIRSCH DIDIER sold $1.28M worth of stock or 20,000 shares. KOH BOON HWEE sold $286,335 worth of stock or 4,500 shares. On Wednesday, December 20 the insider McMullen Michael R. sold $3.06M. On Monday, December 18 the insider Doak Mark sold $1.06 million. Another trade for 5,000 shares valued at $316,300 was sold by Kaltenbach Patrick.

William Von Mueffling decreased its stake in Agilent Technologies Inc (NYSE:A) by 6.62% based on its latest 2017Q4 regulatory filing with the SEC. Cantillon Capital Management Llc sold 322,360 shares as the company’s stock rose 8.72% with the market. The hedge fund run by William Von Mueffling held 4.55M shares of the capital goods company at the end of 2017Q4, valued at $304.60 million, down from 4.87M at the end of the previous reported quarter. Cantillon Capital Management Llc who had been investing in Agilent Technologies Inc for a number of months, seems to be less bullish one the $22.05 billion market cap company. The stock decreased 0.13% or $0.09 during the last trading session, reaching $68.34. About 1.83 million shares traded. Agilent Technologies, Inc. (NYSE:A) has risen 25.96% since February 14, 2017 and is uptrending. It has outperformed by 9.26% the S&P500.

William von Mueffling graduated with an MBA from Columbia in 1995 and went to work immediately in Germany and France for Deutsche Bank. He would later join Lazard Asset Management where he would become the managing director for hedge funds. His rise at Lazard saw him compared to rock stars. Boasting annual average returns of over 30% for 1998 to 2003, Mueffling gained such laudable numbers mostly by the shorting of technology stocks. He would go on to found Cantillon Capital in 2003, and he remains the present and CEO of that firm today. Cantillon Capital Management Llc is a New York-based hedge fund that was founded by William Von Mueffling. It had more than $12.49 billion assets under management in March, 2014. This fund invests only a small percentage of its assets in equities and options. Taken from Cantillon Capital Management latest Adv, the fund reported to have 21 full and part-time employees. Among which 21 performing investment advisory and research functions. The hedge fund had between 11-25 clients.

Agilent Technologies, Inc. (NYSE:A) Ratings Coverage

Among 14 analysts covering Agilent Technologies (NYSE:A), 10 have Buy rating, 0 Sell and 4 Hold. Therefore 71% are positive. Agilent Technologies has $88 highest and $5 lowest target. $68’s average target is -0.50% below currents $68.34 stock price. Agilent Technologies had 53 analyst reports since August 14, 2015 according to SRatingsIntel. On Wednesday, January 18 the stock rating was initiated by Deutsche Bank with “Buy”. The rating was maintained by Barclays Capital on Tuesday, November 21 with “Buy”. The rating was initiated by Deutsche Bank on Thursday, January 7 with “Hold”. On Thursday, October 19 the stock rating was maintained by Robert W. Baird with “Buy”. As per Wednesday, September 20, the company rating was maintained by Jefferies. The company was maintained on Monday, September 18 by Robert W. Baird. The stock of Agilent Technologies, Inc. (NYSE:A) earned “Hold” rating by Deutsche Bank on Wednesday, August 23. The firm has “Hold” rating given on Wednesday, December 20 by Cowen & Co. The stock of Agilent Technologies, Inc. (NYSE:A) has “Buy” rating given on Thursday, August 18 by BTIG Research. Cowen & Co maintained it with “Outperform” rating and $51 target in Thursday, August 18 report.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company has market cap of $22.05 billion. The Company’s Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. It has a 32.54 P/E ratio. The companyÂ’s Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients.

More recent Agilent Technologies, Inc. (NYSE:A) news were published by: Nasdaq.com which released: “Is a Surprise Coming for Agilent Technologies (A) This Earnings Season?” on February 13, 2018. Also Zacks.com published the news titled: “Is a Surprise Coming for Agilent Technologies (A) This Earnings Season …” on February 13, 2018. Streetinsider.com‘s news article titled: “Agilent Technologies (A) Appoints Dow R. Wilson to Board” with publication date: January 18, 2018 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: